You are in::Start > Publications > View > Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission
Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission
Another Publication in an International Scientific Journal
Date
2016
Title
Systemic inflammation and proinflammatory interleukin-17 signalling persist at the end of therapy in patients with metabolic syndrome and psoriasis, reducing the length of remission
Type
Another Publication in an International Scientific Journal
Year
2016
Authors
Coimbra, S
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Oliveira, H
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Neuparth, MJ
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Proenca, JB
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Figueiredo, A
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID
Rocha Pereira, P
(Author)
Other
The person does not belong to the institution.
The person does not belong to the institution.
The person does not belong to the institution.
Without AUTHENTICUS
Without ORCID